홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Trifluoroacetic acid → URAT1 inhibitor 8

HRID 2178114
노트
인쇄 미리보기

반응식

HRID 2178114 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([OH:10])[CH:5]=[CH:6][C:7]=1[CH2:8][OH:9].[C:11]([C:13]1[CH:14]=[C:15]([S:20]([N:23](CC2C=CC(OC)=CC=2OC)[C:24]2[CH:29]=[CH:28][C:27]([F:30])=[CH:26][N:25]=2)(=[O:22])=[O:21])[CH:16]=[CH:17][C:18]=1F)#[N:12].C(=O)([O-])[O-].[K+].[K+].C(O)(C(F)(F)F)=O>CS(C)=O.C(Cl)Cl.CO.CCOC(C)=O.O>[Cl:1][C:2]1[CH:3]=[C:4]([CH:5]=[CH:6][C:7]=1[CH2:8][OH:9])[O:10][C:18]1[CH:17]=[CH:16][C:15]([S:20]([NH:23][C:24]2[CH:29]=[CH:28][C:27]([F:30])=[CH:26][N:25]=2)(=[O:21])=[O:22])=[CH:14][C:13]=1[C:11]#[N:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 4

HCID 6422Trifluoroacetic acidHCID 11430Potassium CarbonateHCID 212878153-Chloro-4-(hydroxymethyl)phenolHCID 1176533623-cyano-N-(2,4-di methoxybenzyl)-4-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide

생성물 1

HCID 86271138URAT1 inhibitor 8수율 26.2%

시약·촉매·용매 5

HCID 679
Dimethyl Sulfoxide
용매
HCID 887Methanol용매
HCID 962Water용매
HCID 6344Dichloromethane용매
HCID 8857Ethyl Acetate용매

실험 절차

To a stirred solution of 3-chloro-4-(hydroxymethyl)phenol (120 mg, 0.54 mmol) and 3-cyano-N-(2,4-di methoxybenzyl)-4-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide (Preparation 18, 100 mg, 0.22 mmol) in DMSO (1.5 mL) was added potassium carbonate (78 mg, 0.56 mmol) and the reaction stirred at room temperature for 72 hours. Water (10 mL) and EtOAc (15 mL) were added and the layers separated. The aqueous phase was extracted with EtOAc. The combined organic extracts were washed with brine, dried over magnesium sulphate and concentrated in vacuo. The crude product was purified by silica gel column chromatography eluting with 3:2 EtOAc:heptanes. The residue (76 mg, 0.13 mmol) was dissolved in DCM (2 mL) and treated with TFA (2 mL). The reaction was stirred at room temperature for 18 hours. MeOH (1 mL) was added and the reaction concentrated in vacuo. The crude product was purified by silica gel column chromatography eluting with 10-30% EtOAc in DCM to afford the title compound (25 mg, 44%) as a colourless solid (25 mg, 44%).

후처리

  1. customthe layers separated
  2. extractionThe aqueous phase was extracted with EtOAc
  3. washThe combined organic extracts were washed with brine
  4. dry with materialdried over magnesium sulphate
  5. concentrationconcentrated in vacuo
  6. customThe crude product was purified by silica gel column chromatography
  7. washeluting with 3:2 EtOAc
  8. stirringThe reaction was stirred at room temperature for 18 hours
  9. concentrationthe reaction concentrated in vacuo
  10. customThe crude product was purified by silica gel column chromatography
  11. washeluting with 10-30% EtOAc in DCM

출처 및 근거

ORD 기록
ord-54adccfd4a814341b5ef42bbcb43ad51
출처 데이터셋
uspto-grants-2015_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09067922B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트